Capricor Therapeutics CAPR
NASDAQ CAPR
$11.22 +2.35 (+26.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Capricor Therapeutics (CAPR) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Capricor Therapeutics' Return on Capital Employed [ROCE] was -42.97% in Q2 2026, up 20.71 percentage points from -63.68% a year earlier but down 3.96 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Capricor Therapeutics came in at -47.56%, down 2.08 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +21.25 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -45.48% in FY2024 (+58.55 pp), -104.03% in FY2023 (+30.19 pp), -134.22% in FY2022 (-72.35 pp) and -61.87% in FY2021 (+6.94 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -356.58% (Q3 2023) and -38.45% (Q4 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +64.40 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 276.50 percentage points); the worst was Q3 2023 (a drop of 271.19 percentage points).
  • Per Business Quant data, CAPR's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -39.00% (Q1 2026), -52.66% (Q4 2025) and -85.10% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Capricor Therapeutics 515.69 Mn -516.56 Mn - -48.04%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -48.04%
Jun 30, 2026 -42.97%
Mar 31, 2026 -39.00%
Dec 31, 2025 -52.66%
Sep 30, 2025 -85.10%
Jun 30, 2025 -63.68%
Mar 31, 2025 -40.98%
Dec 31, 2024 -38.45%
Sep 30, 2024 -80.08%
Jun 30, 2024 -139.51%
Mar 31, 2024 -94.42%
Dec 31, 2023 -144.41%
Sep 30, 2023 -356.58%
Jun 30, 2023 -206.15%
Mar 31, 2023 -202.40%
Dec 31, 2022 -104.48%
Sep 30, 2022 -85.39%
Jun 30, 2022 -61.62%
Mar 31, 2022 -60.84%
Dec 31, 2021 -54.98%
API Access

Capricor Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY